COMMUNIQUÉS West-GlobeNewswire

-
bioAffinity Technologies Joins Early Detection Research Network
01/03/2018 -
Vital Images® Launches Vitrea® Connection Version 7.0 at HIMSS 2018
01/03/2018 -
Articles of Association for Genmab A/S
01/03/2018 -
Imprivata to Showcase Solutions for Positive Identity, Ubiquitous Access, and Multifactor Authentication in Healthcare at 2018 HIMSS Annual Conference
01/03/2018 -
News Release: Proposed combination between Essilor and Luxotticareceives clearance from US Federal Trade Commission without conditions
01/03/2018 -
Communiqué : La Federal Trade Commission (FTC) des Etats-Unis autorise sans condition le projet de rapprochement entre Essilor et Luxottica
01/03/2018 -
MHIB Global Inc. Announces Endorsement by Mood Disorders Society of Canada for Its Program ‘Mental Health in a Box,’ an On-Line Workplace Mental Health Solution for Organizations and Their Employees
01/03/2018 -
Symposium and Panel Discussion on Nymox's Fexapotide To Be Held at American Urological Association Mid-Atlantic Section Annual Meeting on March 3
01/03/2018 -
Cellular Biomedicine Group Invited to Present a Keynote Speech at Phar-East Asia Pharma & Biotech Festival
01/03/2018 -
Sensoria Health Brings Personal, Data-Driven, Interoperable and Reliable Microsoft Azure IoT platform Architecture to Healthcare
01/03/2018 -
TrustedHealth Announces March Token Sale to Increase Global Access to World’s Leading Medical Specialists Through the Blockchain
01/03/2018 -
Cohera Medical, Inc.® submits PMA Supplement to expand indications for TissuGlu® Surgical Adhesive
01/03/2018 -
Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March
01/03/2018 -
Oxford Immunotec Announces Appointment of Mark Klausner to the Board of Directors
01/03/2018 -
Breathtec Biomedical Announces Appointment of CEO
01/03/2018 -
Integrated Healthcare Association (IHA) Releases 2nd Edition of the California Regional Health Care Cost & Quality Atlas
01/03/2018 -
Alphatec Holdings to Report Fourth Quarter and Fiscal Year 2017 Financial Results on March 8, 2018
01/03/2018 -
INSYS Therapeutics Confirms Completion of Founder’s Independent Trust
01/03/2018 -
Helsinn Healthcare S.A.: Eleven finalists have been chosen for the first ever Lyfebulb-Helsinn Innovation Summit & Award in Oncology
01/03/2018
Pages